Study of Integrated Dual Diagnosis Treatment in the Netherlands.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23336

Enrollment

150

Registered

2011-12-07

Start date

2012-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with a Severe Mental Illness with co-occurring alcohol or drug abuse.

Interventions

Treatment as usual: Treatment as usual consists of regular outpatient care according to the principles of FACT. IDDT: In collaboration with the Trimbos Institute and Arkin, a comprehensive IDDT too

1. Have knowledge of substance abuse and addiction

2. Are trained in standardized assessment of substance abuse

3. Are familiar with the stages as defined by Prochaska and Diclemente

4. Will be trained in motivational interviewing techniques. In each team, one team member will be given the task to monitor, and support the execution of IDDT. Also, an addiction specialist, someone

Eligibility

Inclusion criteria

Inclusion criteria: All patients in Mental Health Care (MHC) outpatient teams with a SMI defined as: 1. A diagnosis of schizophrenia or major affective disorder; 2. With a duration of at least 2 years; 3. Severe disability in terms of role functioning; 4. A co-occurring Substance Use Disorder (SUD).

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have inadequate mastery of the Dutch language.

Design outcomes

Primary

Measure	Time frame
1. Type and severity of psychiatric symptoms (BPRS-E); 2. Level of substance abuse (MATE).	—

Secondary

Measure	Time frame
On a patient level we will use the following secondary outcomes: 1. Patients acceptance and adherence to their treatment (CRS); 2. Quality of life (MANSA); 3. Functioning (GAF); 4. stage of substance abuse treatment (SATS); 5. Therapeutical alliance (HAQ). To study the effects of IDDT training on professional’s therapeutic skills, attitude, knowledge, and fidelity we will use the following secondary outcomes: 1. Mastering of motivational interviewing techniques (MITI); 2. Theoretical knowledge concerning substance abuse (paper test); 3. Team IDDT fidelity (standardized fidelity assessment).	—

Measure

Time frame

On a patient level we will use the following secondary outcomes: 1. Patients acceptance and adherence to their treatment (CRS); 2. Quality of life (MANSA); 3. Functioning (GAF); 4. stage of substance abuse treatment (SATS); 5. Therapeutical alliance (HAQ). To study the effects of IDDT training on professional’s therapeutic skills, attitude, knowledge, and fidelity we will use the following secondary outcomes: 1. Mastering of motivational interviewing techniques (MITI); 2. Theoretical knowledge concerning substance abuse (paper test); 3. Team IDDT fidelity (standardized fidelity assessment).

—

Contacts

Public ContactM.J. Kikkert

Arkin Academy Klaprozenweg 111

martijn.kikkert@arkin.nl+31 (0)20 5904422

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)